FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to gynaecology and can be used for express diagnostics of necrotic suppurative tissue destruction in inflammatory diseases of uterine appendages. The clinical signs are determined and in observed inflammatory diseases of uterine appendages, blood is sampled to analyse blood plasma for the content of fibrin-monomer complexes (FMC) and fibrinogen count (FG), and to calculate the destruction factor D by formula: D=FMC/FG, where: FMC is soluble fibrin-monomer complex count in blood, mg/%, FG is fibrinogen count in blood, g/l. If D is equal to and more than 2.9, necrotic suppurative destruction in uterine appendages is considered to be observed, and the values less than 2.9 show the absence of destruction in uterine appendages.
EFFECT: method allows reducing time and improving quality of diagnostics that provides a basis for well-timed therapeutic approach adequate to the clinical situation.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE OF POSTOPERATIVE PERIOD IN PATIENTS WITH INFLAMMATORY DISEASES IN UTERINE APPENDAGES FOLLOWING CONSERVATIVE LAPAROSCOPIC SURGERIES | 2008 |
|
RU2389437C1 |
| METHOD OF DIAGNOSING PURULENT-NECROTIC DESTRUCTION IN UTERINE APPENDAGES IN CASE OF LOCALISED PERITONITIS | 2009 |
|
RU2402778C1 |
| METHOD FOR ASSESSING SEVERITY OF INFLAMMATORY PELVIC DISEASES | 2015 |
|
RU2602914C1 |
| METHOD OF PREDICTION OF AUTOINTOXICATION SEVERITY ASSOCIATED WITH SUPPURATIVE INFLAMMATORY DISEASES OF UTERINE APPENDAGES | 2007 |
|
RU2341796C1 |
| PREDICTION METHOD FOR PROBABILITY OF SEVERE DESTRUCTIVE PROCESS DEVELOPMENT IN PYOINFLAMMATORY CONDITIONS OF UTERINE APPENDAGES | 2007 |
|
RU2345362C1 |
| METHOD FOR PREDICTING PURULENT-NECROTIC TISSUE DESTRUCTION AND THE SCOPE OF THE PROCESS AT INFLAMMATORY DISEASES OF UTERINE ADNEXA | 2005 |
|
RU2295134C1 |
| METHOD FOR SELECTING TREATMENT METHOD AND SURGICAL ACCESS IN SUPPURATIVE INFLAMMATORY UTERINE APPENDAGES DISEASES | 2005 |
|
RU2303263C1 |
| METHOD FOR DIAGNOSIS OF METASTASES TO LYMPH NODES OF SMALL PELVIS IN PATIENTS WITH RESECTABLE CERVICAL CANCER | 2020 |
|
RU2750769C2 |
| METHOD OF CHOOSING THERAPEUTIC APPROACH TO INFLAMMATORY DISEASES OF INTERNAL FEMALE GENITAL ORGANS | 2010 |
|
RU2498302C2 |
| METHOD FOR DETERMINING HEMOSTASIS CRITERIA FOR PREDICTING UNFAVORABLE SEPSIS OUTCOME IN ACUTE MYELOBLASTOSIS CASES | 2006 |
|
RU2320996C1 |
